270 related articles for article (PubMed ID: 24712007)
1. [Medical treatment of soft tissue sarcomas based on the histological subtype].
Pápai Z
Magy Onkol; 2014 Mar; 58(1):53-8. PubMed ID: 24712007
[TBL] [Abstract][Full Text] [Related]
2. Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas.
Casali PG
Ann Oncol; 2012 Sep; 23 Suppl 10():x167-9. PubMed ID: 22987955
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas.
Edmonson JH; Long HJ; Richardson RL; Creagan ET; Green SJ
Cancer Chemother Pharmacol; 1985; 15(2):181-2. PubMed ID: 2990751
[TBL] [Abstract][Full Text] [Related]
4. Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrations.
Verweij J; Baker LH
Eur J Cancer; 2010 Mar; 46(5):863-8. PubMed ID: 20138507
[TBL] [Abstract][Full Text] [Related]
5. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.
Sethi TK; Keedy VL
Curr Treat Options Oncol; 2016 Feb; 17(2):11. PubMed ID: 26931561
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for soft tissue sarcomas.
Ravi V; Patel S
Surg Oncol Clin N Am; 2012 Apr; 21(2):243-53. PubMed ID: 22365517
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines].
Italiano A; Toulmonde M; Bui-Nguyen B
Bull Cancer; 2010 Jun; 97(6):679-86. PubMed ID: 20483708
[TBL] [Abstract][Full Text] [Related]
8. Emerging therapies for adult soft tissue sarcoma.
Radaelli S; Stacchiotti S; Casali PG; Gronchi A
Expert Rev Anticancer Ther; 2014 Jun; 14(6):689-704. PubMed ID: 24555529
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma.
Mahmood ST; Agresta S; Vigil CE; Zhao X; Han G; D'Amato G; Calitri CE; Dean M; Garrett C; Schell MJ; Antonia S; Chiappori A
Int J Cancer; 2011 Oct; 129(8):1963-9. PubMed ID: 21154746
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study
Gelderblom H; Judson IR; Benson C; Merimsky O; Grignani G; Katz D; Freivogel KW; Stein D; Jobanputra M; Mungul A; Manson SC; Sanfilippo R
Acta Oncol; 2017 Dec; 56(12):1769-1775. PubMed ID: 28723233
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.
De Sanctis R; Marrari A; Marchetti S; Mussi C; Balzarini L; Lutman FR; Daolio P; Bastoni S; Bertuzzi AF; Quagliuolo V; Santoro A
Drug Des Devel Ther; 2015; 9():5785-91. PubMed ID: 26604682
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of disseminated sarcomas of the soft tissues].
Klimenkov AA; Musatov VK; Karapetian RM
Vopr Onkol; 1973; 19(7):72-81. PubMed ID: 4359262
[No Abstract] [Full Text] [Related]
13. Role of chemotherapy in the management of soft tissue sarcomas.
Krikelis D; Judson I
Expert Rev Anticancer Ther; 2010 Feb; 10(2):249-60. PubMed ID: 20132000
[TBL] [Abstract][Full Text] [Related]
14. Proceedings: Chemotherapy of soft-tissue sarcomas.
Talley RW
Proc Natl Cancer Conf; 1972; 7():89-900. PubMed ID: 4358072
[No Abstract] [Full Text] [Related]
15. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
Ryan CW; Desai J
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
[TBL] [Abstract][Full Text] [Related]
16. Histology-driven chemotherapy in soft tissue sarcomas.
Scurr M
Curr Treat Options Oncol; 2011 Mar; 12(1):32-45. PubMed ID: 21359911
[TBL] [Abstract][Full Text] [Related]
17. [Soft tissue sarcomas and gastrointestinal stromal tumors].
Reichardt P
Internist (Berl); 2016 Mar; 57(3):245-56. PubMed ID: 26907871
[TBL] [Abstract][Full Text] [Related]
18. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
Kopp HG; Patel S; Brücher B; Hartmann JT
Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma.
Hartmann JT; Patel S
Drugs; 2005; 65(2):167-78. PubMed ID: 15631540
[TBL] [Abstract][Full Text] [Related]
20. [Molecular biology of sarcoma and therapeutic choices].
Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]